Linkage to office-based buprenorphine treatment reduced illicit opioid use and increased days of buprenorphine treatment in patients discharged from a short-term detoxification program.
Marijuana use is risky for young people and pregnant women.
Investigators noted a significant increase in the odds of concurrent and subsequent marijuana use in adolescents and young adults who used e-cigarettes.
Opioid deaths decreased during January to July 2018, while deaths from illicitly manufactured fentanyl (IMF) increased during the same period.
More than 60% of young adults who reported nonmedical prescription opioid use in the previous 30 days screened positive for depressive symptomology using the Center for Epidemiologic Studies Short Depression Scale.
Americans should not use electronic cigarettes while health officials investigate cases of severe lung illness that may be linked to the devices.
OxyContin maker Purdue Pharma has reached a tentative settlement with a coalition of states and local governments that sued the company over its role in America’s ongoing opioid crisis.
Settlement talks with OxyContin maker Purdue Pharma over its role in the U.S. opioid crisis have reached a stalemate and the company is expected to file for bankruptcy.
Recognizing prescription opioid dependence and expanding the use of buprenorphine could improve the quality of life for patients with chronic pain.
Nearly $2 billion in grants to help fight the US opioid epidemic will be handed out to states and local governments.